Duloxetine: A Balanced and Selective Norepinephrine and Serotonin-Reuptake Inhibitor

Anders D. Westanmo; Jon Gayken; Robert Haight


Am J Health Syst Pharm. 2005;62(23):2481-2490. 

In This Article


Duloxetine has been approved for the treatment of MDD and pain associated with diabetic peripheral neuropathy in adults. Although it is uncertain whether duloxetine will increase remission rates beyond those of currently available therapies for major depression, it may be a suitable alternative for patients who cannot tolerate or have poor outcomes with other antidepressant agents.